Clinical Trial Update: A Study of Remimazolam Tosilate for Sedation in the Upper Gastrointestinal Endoscopy [Phase 4]

View source ↗

Summary

Phase 4 trial update on remimazolam tosilate for sedation during upper gastrointestinal endoscopy has completed recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sedation in the Upper Gastrointestinal Endoscopy

Drugs mentioned

• Remimazolam Tosilate (remimazolam)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Sedation in the Upper Gastrointestinal Endoscopy | Phase 4 | Status: COMPLETED